Liu X - Search Results

1

The triple combination DBDx alleviates cytokine storm and related lung injury.

Yu Z, Li Y, Bai L, Zheng Y, Liu X, Zhen Y. Yu Z, et al. Among authors: liu x. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113431. doi: 10.1016/j.intimp.2024.113431. Epub 2024 Oct 25. Int Immunopharmacol. 2024. PMID: 39454409

2

Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.

Gong JH, Liu XJ, Li Y, Zhen YS. Gong JH, et al. Cancer Chemother Pharmacol. 2012 May;69(5):1323-32. doi: 10.1007/s00280-012-1827-9. Epub 2012 Feb 5. Cancer Chemother Pharmacol. 2012. PMID: 22311160

3

A multifunctional drug combination shows highly potent therapeutic efficacy against human cancer xenografts in athymic mice.

Liu XJ, Zheng YB, Li Y, Wu SY, Zhen YS. Liu XJ, et al. PLoS One. 2014 Dec 22;9(12):e115790. doi: 10.1371/journal.pone.0115790. eCollection 2014. PLoS One. 2014. PMID: 25531414 Free PMC article.

4

A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway.

Gong J, Zheng Y, Wang Y, Sheng W, Li Y, Liu X, Si S, Shao R, Zhen Y. Gong J, et al. Among authors: liu x. PLoS One. 2018 Feb 2;13(2):e0191984. doi: 10.1371/journal.pone.0191984. eCollection 2018. PLoS One. 2018. PMID: 29394294 Free PMC article.

5

DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic mice.

Zheng YB, Zhang MR, Li Y, Liu XJ, Zhen YS. Zheng YB, et al. Cancer Biol Ther. 2020 Aug 2;21(8):749-757. doi: 10.1080/15384047.2020.1776580. Epub 2020 Jun 17. Cancer Biol Ther. 2020. PMID: 32644888 Free PMC article.

6

[Inhibitory effect of lidamycin on growth of colon carcinoma 26 and hepatic metastasis in mice].

Liu XJ, Dai Y, Shang Y, Li Y, Zhen YS. Liu XJ, et al. Ai Zheng. 2005 Jun;24(6):641-5. Ai Zheng. 2005. PMID: 15946470 Chinese.

7

[Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].

Dai Y, Liu XJ, Zhen YS. Dai Y, et al. Yao Xue Xue Bao. 2006 Jan;41(1):41-6. Yao Xue Xue Bao. 2006. PMID: 16683526 Chinese.

8

Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.

Liu H, Li L, Li XQ, Liu XJ, Zhen YS. Liu H, et al. Anticancer Drugs. 2009 Jan;20(1):41-9. doi: 10.1097/CAD.0b013e328318292c. Anticancer Drugs. 2009. PMID: 19342999

9

MMP-2/9-oriented combinations enhance antitumor efficacy of EGFR/HER2-targeting fusion proteins and gemcitabine.

Qin Y, Liu XJ, Li L, Liu XJ, Li Y, Gao RJ, Shao RG, Zhen YS. Qin Y, et al. Oncol Rep. 2014 Jul;32(1):121-30. doi: 10.3892/or.2014.3169. Epub 2014 May 7. Oncol Rep. 2014. PMID: 24807584

10

Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.

Liu WJ, Liu XJ, Li L, Li Y, Zhang SH, Zhen YS. Liu WJ, et al. Cancer Immunol Immunother. 2014 Dec;63(12):1261-72. doi: 10.1007/s00262-014-1604-1. Epub 2014 Aug 28. Cancer Immunol Immunother. 2014. PMID: 25164878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,350 results

Search Page

Filters